Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-10T05:33:20.691Z Has data issue: false hasContentIssue false
  • English
  • Français

Is Intranasal Ketamine Safe and Effective as a Prehospital Analgesic?

Published online by Cambridge University Press:  12 November 2019

Brett H. Shaw Open the ORCID record for Brett H. Shaw [Opens in a new window]  and
Marshall Ross
Brett H. Shaw*
Affiliation:
Department of Emergency Medicine, University of Calgary, Calgary, AB, Canada
Marshall Ross
Affiliation:
Department of Emergency Medicine, University of Calgary, Calgary, AB, Canada
*
Correspondence to: Dr. Brett Shaw, Department of Emergency Medicine, University of Calgary, C231 3280 Hospital Dr. NW, Calgary, ABT2N 4Z6, Canada; Email: brett.shaw@ucalgary.ca

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Keywords

Emergency medicineanesthesia and analgesiaprehospital / EMS
Type
Commentary
Information
Canadian Journal of Emergency Medicine , Volume 22 , Issue 1 , January 2020 , pp. 31 - 32
Copyright
Copyright © Canadian Association of Emergency Physicians 2019

Abstract Link:https://www.ncbi.nlm.nih.gov/pubmed/30926189

Full Citation: G. Andolfatto, K. Innes, W. Dick, S. Jenneson, E. Willman, R. Stenstrom, P.J. Zed, G, Benoit. Prehospital analgesia with intranasal ketamine (PAIN-K): a randomized double-blind trial in adults. Ann Emerg Med 2019;74(2):241–50.

Article type: Therapy.

Ratings: Methods – 4 Usefulness – 3

INTRODUCTION

Background

Primary care paramedics in British Columbia, Canada, have limited analgesic options other than nitrous oxide when transporting patients. Ketamine can be an effective analgesic when dosed appropriately.

Objective

The aim of this study was to compare the improvement in pain scores between intranasal ketamine and placebo when added to baseline inhaled nitrous oxide.

METHODS

Design

Single-centre randomized double blind control trial.

Setting

Out-of-hospital patients being cared for by primary care paramedics dispatched from a single station.

Subjects

Out-of-hospital patients with acute pain who reported a verbal numeric rating scale pain score ≥ 5, and who wished to receive analgesia.

Intervention

0.75 mg/kg intranasal ketamine v. placebo, both in addition to baseline nitrous oxide administration.

Outcomes

Primary outcome was the proportion of patients experiencing a reduction in verbal numeric rating scale score ≥ 2 at 30 minutes.

RESULTS

The key findings are displayed in Table 1.

Table 1. Key findings

CI, confidence interval; IQR = interquartile range; no. = number; VNRS = verbal numeric rating scale.

APPRAISAL

Strengths

  • • True randomization

  • • Similarity between treatment and placebo groups

  • • Blinded and placebo controlled

  • • No patients were lost to follow-up after randomization

  • • Strong external validity and applicability

Limitations

  • • There was a component of unblinding with providers often able to identify treatment arms.

  • • There were no reported outcomes for patients beyond 30 minutes to better understand duration of treatment effect.

  • • Not all patients received nitrous oxide, limiting conclusions made about the combined effects of ketamine and nitrous oxide.

  • • This study was likely insufficiently powered to pick up rare adverse events.

CONTEXT

The role for ketamine as an analgesic in both the emergency department and prehospital setting is an evolving area with limited high quality evidence to guide practice.Reference Ghate, Clark and Vaillancourt1 A systematic review examining the utility of sub-dissociative doses of intravenous ketamine found it to be a generally effective, opioid sparing analgesic option.Reference Ghate, Clark and Vaillancourt1 Recent studies have compared the effects of intranasal ketamine with standard therapy for renal colicReference Mozafari, Maleki Verki, Motamed, Sabouhi and Tirandaz2 and primary headaches.Reference Benish, Villalobos and Love3 Both studies did not find ketamine alone to be superior to standard therapy, but believed it provided a reasonable analgesic effect.

BOTTOM LINE

The PAIN-K study provides evidence that intranasal ketamine appears to be a potentially efficacious prehospital analgesic. Although this study was likely not powered to detect rare, serious adverse events, intranasal ketamine was quite well tolerated in the intervention group. In prehospital settings, it may be more difficult to obtain IV access; therefore, intranasal analgesic options are of increased importance. To the best of our knowledge, this is the first study to examine sub-dissociative dose intranasal ketamine for analgesia in a prehospital setting.

References

REFERENCES

1.Ghate, G, Clark, E, Vaillancourt, C.Systematic review of the use of low-dose ketamine for analgesia in the emergency department. Can J Emerg Med 2018;20(1):36–45.Google ScholarPubMed
2.Mozafari, J, Maleki Verki, M, Motamed, H, Sabouhi, A, Tirandaz, F.Comparing intranasal ketamine with intravenous fentanyl in reducing pain in patients with renal colic: a double-blind randomized clinical trial. Am J Emerg Med 2019; epub, doi: 10.1016/j.ajem.2019.05.049.CrossRefGoogle ScholarPubMed
3.Benish, T, Villalobos, D, Love, S, et al. The THINK (Treatment of Headache with Intranasal Ketamine) trial: a randomized controlled trial comparing intranasal ketamine with intravenous metoclopramide. J Emerg Med 2019;56(3):248–57.e1.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Key findings